Certuity’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,386
| Closed | -$208K | – | 362 |
|
|
2024
Q1 | $208K | Buy |
+2,386
| New | +$208K | 0.02% | 303 |
|
|
2023
Q4 | – | Sell |
-2,296
| Closed | -$203K | – | 349 |
|
|
2023
Q3 | $203K | Buy |
+2,296
| New | +$203K | 0.02% | 242 |
|
|
2023
Q2 | – | Sell |
-2,603
| Closed | -$253K | – | 268 |
|
|
2023
Q1 | $253K | Buy |
2,603
+83
| +3% | +$8.07K | 0.04% | 179 |
|
|
2022
Q4 | $261K | Sell |
2,520
-4,904
| -66% | -$508K | 0.04% | 165 |
|
|
2022
Q3 | $629K | Buy |
7,424
+4,207
| +131% | +$356K | 0.15% | 73 |
|
|
2022
Q2 | $267K | Sell |
3,217
-674
| -17% | -$55.9K | 0.07% | 167 |
|
|
2022
Q1 | $300K | Buy |
3,891
+768
| +25% | +$59.2K | 0.06% | 208 |
|
|
2021
Q4 | $276K | Buy |
3,123
+494
| +19% | +$43.7K | 0.06% | 227 |
|
|
2021
Q3 | $203K | Buy |
+2,629
| New | +$203K | 0.04% | 361 |
|
|
2020
Q2 | – | Sell |
-3,200
| Closed | -$264K | – | 167 |
|
|
2020
Q1 | $264K | Hold |
3,200
| – | – | 0.15% | 108 |
|
|
2019
Q4 | $271K | Buy |
+3,200
| New | +$271K | 0.13% | 123 |
|